CDS | Jotup

Nutrien Declares Quarterly Dividend of US$0.54 per Share

Retrieved on:

Mercoledì, Maggio 8, 2024

Agriculture, Natural Resources, NTR, TSX, Bank, Depository Trust Company, Cede and Company, Income Tax Act, CDS, Security (finance)

Nutrien Ltd. (TSX and NYSE: NTR) announced today that its Board of Directors has declared a quarterly dividend of US$0.54 per share payable on July 19, 2024, to shareholders of record on June 28, 2024.

Key Points:

Nutrien Ltd. (TSX and NYSE: NTR) announced today that its Board of Directors has declared a quarterly dividend of US$0.54 per share payable on July 19, 2024, to shareholders of record on June 28, 2024.
However, registered shareholders of Nutrien may elect to change the currency of their dividend payments to US dollars or Canadian dollars, as applicable.
In addition, Nutrien offers registered shareholders direct deposit by electronic funds transfer for dividend payments.
All dividends paid by Nutrien are, pursuant to subsection 89(14) of the Income Tax Act (Canada), designated as eligible dividends.

Waters ACQUITY QDa II Mass Detector Delivers Wider Range of Chemical Analysis within Cost-Effective, Lower Energy Instrument

Retrieved on:

Mercoledì, Maggio 8, 2024

ACT, C-peptide, Chromatography software, Mass, Analytic, Research, LC-MS, Waters Corporation, API, Food, CDS, Mass spectrometry, WAT

MILFORD, Mass., May 8, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today announced the release of the ACQUITY QDa II Mass Detector, the evolution of its highly successful, compact, and streamlined mass detection instrument that delivers high-quality, mass spectral data to chromatographic separations. This new and improved mass detector allows scientists to analyze a wider range of chemical entities with a robust, cost-effective, low energy consumption solution. It enhances and complements Waters best-in-class ACQUITY Premier Liquid Chromatography (LC) separations portfolio to enable flexible analysis of both small and large molecules across pharmaceutical, food, chemical, and materials applications.

Key Points:

MILFORD, Mass., May 8, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today announced the release of the ACQUITY QDa II Mass Detector, the evolution of its highly successful, compact, and streamlined mass detection instrument that delivers high-quality, mass spectral data to chromatographic separations.
This new and improved mass detector allows scientists to analyze a wider range of chemical entities with a robust, cost-effective, low energy consumption solution.
The ACQUITY QDa II Mass Detector is designed to seamlessly integrate into existing laboratory workflows with the usability and format of a LC detector.
The ACQUITY QDa II Mass Detector is designed for compliance-ready deployment on Waters Empower™ Chromatography Data System (CDS) Software.

Waters ACQUITY QDa II Mass Detector Delivers Wider Range of Chemical Analysis within Cost-Effective, Lower Energy Instrument

Retrieved on:

Mercoledì, Maggio 8, 2024

ACT, C-peptide, Chromatography software, Mass, Analytic, Research, LC-MS, Waters Corporation, API, Food, CDS, Mass spectrometry, WAT, Fine chemical

MILFORD, Mass., May 8, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today announced the release of the ACQUITY QDa II Mass Detector, the evolution of its highly successful, compact, and streamlined mass detection instrument that delivers high-quality, mass spectral data to chromatographic separations. This new and improved mass detector allows scientists to analyze a wider range of chemical entities with a robust, cost-effective, low energy consumption solution. It enhances and complements Waters best-in-class ACQUITY Premier Liquid Chromatography (LC) separations portfolio to enable flexible analysis of both small and large molecules across pharmaceutical, food, chemical, and materials applications.

Key Points:

MILFORD, Mass., May 8, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today announced the release of the ACQUITY QDa II Mass Detector, the evolution of its highly successful, compact, and streamlined mass detection instrument that delivers high-quality, mass spectral data to chromatographic separations.
This new and improved mass detector allows scientists to analyze a wider range of chemical entities with a robust, cost-effective, low energy consumption solution.
The ACQUITY QDa II Mass Detector is designed to seamlessly integrate into existing laboratory workflows with the usability and format of a LC detector.
The ACQUITY QDa II Mass Detector is designed for compliance-ready deployment on Waters Empower™ Chromatography Data System (CDS) Software.

Excision BioTherapeutics to Present Positive Data from its HSV-1 Keratitis Program, EBT-104, at the ASGCT 2024 Annual Meeting

Retrieved on:

Lunedì, Aprile 22, 2024

Herpes Simplex Keratitis (HSK), caused by the infection of herpes simplex virus type 1 (HSV-1) in the cornea, is a major cause of blindness worldwide.

Key Points:

Herpes Simplex Keratitis (HSK), caused by the infection of herpes simplex virus type 1 (HSV-1) in the cornea, is a major cause of blindness worldwide.
Although current anti-HSV-1 therapies interfere with viral DNA replication, they do not eliminate HSV-1 reservoirs or prevent recurrence.
CRISPR/Cas-mediated gene editing can potentially address the underlying causes of the disease by directly eliminating the latent HSV-1 reservoirs.
The 440 guide RNA pairs formed with these 42 PlmCasX guide RNAs were tested in tissue culture for DNA excision efficiency.

Turning Point Brands Announces First Quarter 2024 Results

Retrieved on:

Giovedì, Maggio 2, 2024

Online Retail, Retail, Tobacco, Specialty, Convenience Store, MST, FDA, Clipper, Zigzag, Webcast, Growth, CDS, EPS, FRE, Adjustment, TPB, Wrap (food), ID, GAAP

(“TPB” or “the Company”) (NYSE: TPB), a manufacturer, marketer and distributor of branded consumer products, including alternative smoking accessories and consumables with active ingredients, announced today financial results for the first quarter ended March 31, 2024.

Key Points:

(“TPB” or “the Company”) (NYSE: TPB), a manufacturer, marketer and distributor of branded consumer products, including alternative smoking accessories and consumables with active ingredients, announced today financial results for the first quarter ended March 31, 2024.
For the quarter, the Zig-Zag Products segment gross profit increased 23.0% to $27.5 million.
For the first quarter, CDS net sales were $14.0 million, gross profit was $3.6 million, and gross margin was 25.4%.
As previously disclosed, a conference call with the investment community to review TPB’s financial results has been scheduled for 10:00 a.m. Eastern on Thursday, May 2, 2024.

Crucial Data Solutions Introduces TrialKit PACS to Streamline Image Management in Clinical Trials

Retrieved on:

Martedì, Aprile 23, 2024

Crucial Data Solutions (CDS), a leading provider of data collection and trial management software to advance clinical research, today announced the launch of TrialKit PACS .

Key Points:

Crucial Data Solutions (CDS), a leading provider of data collection and trial management software to advance clinical research, today announced the launch of TrialKit PACS .
This innovative solution streamlines medical image management within clinical trials, offering a unified platform for all data collection and management needs.
TrialKit PACS streamlines medical image capture into EDC trials by eliminating the time and cost of third party systems licensing and integration.
Founded in 2010, Crucial Data Solutions (CDS) provides the most innovative data collection and clinical trial management technology on the market today.

WASTE CONNECTIONS ANNOUNCES REGULAR QUARTERLY CASH DIVIDEND

Retrieved on:

Mercoledì, Aprile 24, 2024

WCN, Waste Connections, DTC, Bank, Computershare, CDS

TORONTO, April 24, 2024 /PRNewswire/ -- Waste Connections, Inc. (TSX/NYSE: WCN) ("Waste Connections" or the "Company") today announced that its Board of Directors has declared a regular quarterly cash dividend of $0.285 U.S. per common share of the Company.

Key Points:

TORONTO, April 24, 2024 /PRNewswire/ -- Waste Connections, Inc. (TSX/NYSE: WCN) ("Waste Connections" or the "Company") today announced that its Board of Directors has declared a regular quarterly cash dividend of $0.285 U.S. per common share of the Company.
The regular quarterly cash dividend will be paid on May 23, 2024 to shareholders of record at the close of business on May 8, 2024.
The Board intends to review the quarterly dividend each October, with a long-term objective of increasing the amount of the dividend.
Shareholders of Waste Connections whose common shares are held by a bank or broker that participates in U.S. depositary DTC will receive payment of their dividends in U.S. dollars.

FDB Targeted Medication Warnings™ Earns Epic Toolbox Designation

Retrieved on:

Martedì, Aprile 23, 2024

Health Level 7, Hospital, FHIR, EHR, Software, Epic Systems, API, Toolbox, SMART, Medication, Patient safety, FDB, Patient, CDS, Health, First Databank, Pharmacist, SAN, Pharmaceutical industry

SOUTH SAN FRANCISCO, Calif., April 23, 2024 /PRNewswire/ -- FDB (First Databank, Inc.), the leading provider of drug knowledge that helps healthcare professionals make precise decisions, announced today that its FDB Targeted Medication Warnings™ solution has earned the new Toolbox designation from Epic Systems Corporation in the Medication Dosing Decision Support Toolbox category.

Key Points:

SOUTH SAN FRANCISCO, Calif., April 23, 2024 /PRNewswire/ -- FDB (First Databank, Inc.), the leading provider of drug knowledge that helps healthcare professionals make precise decisions, announced today that its FDB Targeted Medication Warnings™ solution has earned the new Toolbox designation from Epic Systems Corporation in the Medication Dosing Decision Support Toolbox category.
FDB Targeted Medication Warnings is part of the FDB PatientFirst™ suite of clinical decision support (CDS) solutions.
Several factors supported Targeted Medication Warnings' Toolbox designation, including its recently announced integration with CDS Hooks *.
Epic customers who want to learn more about how they can enhance efficiency for clinicians while improving patient safety and quality of patient care through advanced patient-specific medication decision support can find FDB Targeted Medication Warnings at vendorservices.epic.com/Showroom/Listing?id=851.

Arcfield awarded $93M follow-on contract to continue development of cross-domain cyber solutions with U.S. Air Force

Retrieved on:

Martedì, Aprile 16, 2024

Transfer, Intelligence, Intelligence community, Research, Partnership, AFRL, Support, Classification, CDS, Air Force Research Laboratory

CHANTILLY, Va., April 16, 2024 /PRNewswire/ -- Arcfield, a leading government technology and mission support provider, announced today that it was awarded the X-Domain Technology Through Research, Evolution, Enhancement, Maintenance and Support – Next Generation (XTREEMS-NG) contract from the Air Force Research Laboratory (AFRL).

Key Points:

CHANTILLY, Va., April 16, 2024 /PRNewswire/ -- Arcfield, a leading government technology and mission support provider, announced today that it was awarded the X-Domain Technology Through Research, Evolution, Enhancement, Maintenance and Support – Next Generation (XTREEMS-NG) contract from the Air Force Research Laboratory (AFRL).
This award has a total value of more than $93 million over five years and represents follow-on work for the company.
Under the program, Arcfield will continue its full life cycle support of the AFRL Information Support Server Environment (ISSE) and X-domain Agile Rules-Based Information Transfer OrchestratoR ( X-ARBITOR ) cross-domain solution (CDS) and associated suite of technologies.
"We are thrilled to extend our partnership with AFRL on the next-generation XTREEMS program," said Kevin Kelly, chairman and chief executive officer, Arcfield.

Lundin Mining Announces Dates of Annual and Special Meeting of Shareholders and First Quarter 2024 Results

Retrieved on:

Venerdì, Aprile 12, 2024

VANCOUVER, BC, April 12, 2024 /PRNewswire/ -- (TSX: LUN) (Nasdaq Stockholm: LUMI) Lundin Mining Corporation ("Lundin Mining" or the "Company") today announces that its Annual and Special Meeting will be held on Friday, May 10, 2024 (the "Meeting") at 10:00 a.m. Vancouver time as a hybrid format.

Key Points:

VANCOUVER, BC, April 12, 2024 /PRNewswire/ -- (TSX: LUN) (Nasdaq Stockholm: LUMI) Lundin Mining Corporation ("Lundin Mining" or the "Company") today announces that its Annual and Special Meeting will be held on Friday, May 10, 2024 (the "Meeting") at 10:00 a.m. Vancouver time as a hybrid format.
To facilitate increased shareholder attendance and participation, the Company has made arrangements to enable shareholders and proxyholders to attend and vote virtually and in-person at this year's Meeting.
Detailed information on how shareholders can participate in the Meeting and vote is available in the Circular.
Shareholders who hold Euroclear Registered Securities are not registered holders of voting securities for the purposes of voting at the Meeting.